Article Text

Download PDFPDF
Cochrane review on HPV vaccination is not misleading
  1. Cynthia Farquhar
  1. Correspondence to Dr Cynthia Farquhar, Obstetrics and Gynaecology, University of Auckland, Auckland 1142, New Zealand; c.farquhar{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Re Jørgensen L, Gøtzsche PC, Jefferson T. The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias. BMJ Evidence-Based Medicine 2018. doi:10.1136/bmjebm-2018-111012. 

I write with regard to this publication concerning the Cochrane human papillomavirus (HPV) vaccine review published May 2018.1 The views expressed in this letter are entirely my own and not those of the institutions I work for or of the Cochrane Collaboration. However, I wish to make the following observations.

The authors of the BMJ Evidence-Based Medicine (BMJ EBM) article contend that almost half the data were ‘missing’. The additional data that the authors of the BMJ EBM article refer to were only available because of an extensive search in pharmaceutical and registry data over several years.2 While it is admirable that this work was undertaken, it is unclear if the addition of these data would have made a difference to the conclusions of the review. With more than 35 000 women in the Cochrane review, the reported benefits of HPV vaccination in terms of reducing cervical dysplasia and treatments for cervical dysplasia are not in doubt. …

View Full Text


  • Contributors CF wrote this letter.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.